Nerve growth factor eye drops improve visual acuity and electrofunctional activity in Age-related macular degeneration: A case report

Annali dell'Istituto Superiore di Sanita

Volumn 45, Issue 4, 2009, Pages 439-442

  Lambiase, Alessandro ^a   Coassin, Marco ^a   Tirassa, Paola ^b   Mantelli, Flavio ^a   Aloe, Luigi ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b CNR   (Italy)

Author keywords

Eye drops; Macular degeneration; Nerve growth factor; Retina; Visual pathways

Indexed keywords

EID: 73849104545     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0021-25712009000400014     Document Type: Article

References (31)

1. Lambiase A, Coassin M, Sposato V, Micera A, Sacchetti M, Bonini S, Aloe L. NGF topical application in patients with corneal ulcer does not generate circulating NGF antibodies. Pharmacol Res 2007;56:65-9.
2. Lambiase A, Manni L, Rama P, Bonini S. Clinical application of nerve growth factor on human corneal ulcer. Arch Ital Biol 2003;141:141-8.
3. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998;338:1174-80.
4. Generini S, Tuveri MA, Matucci Cerinic M, Mastinu F, Manni L, Aloe L. Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. Exp Clin Endocrinol Diabetes 2004;112:542-4.
5. Aloe L. Nerve growth factor, human skin ulcers and vascularization. Our experience. Prog Brain Res 2004;146:515-22.
6. Micera A, Lambiase A, Stampachiacchiere B, Bonini S, Levi-Schaffer F. Nerve growth factor and tissue repair remodeling: trkA (NGFR) and p75 (NTR), two receptors one fate. Cytokine Growth Factor Rev 2007;18:245-56.
7. Aloe L, Tuveri MA. Nerve growth factor and autoimmune rheumatic diseases. Clin Exp Rheumatol 1997;15:433-8.
8. Bernabei R, Landi F, Bonini S, et al. Effect of topical application of nerve-growth factor on pressure ulcers. Lancet 1999;354:07.
9. Tuveri M, Generini S, Matucci-Cerinic M, Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 2000;356:1739-40.
10. Coassin M, Lambiase A, Sposato V, Micera A, Bonini S, Aloe L. Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefes Arch Clin Exp Ophthalmol 2008;246:1743-9.
11. Sposato V, Bucci MG, Coassin M, Russo MA, Lambiase A, Aloe L. Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma. Neurosci Lett 2008;446:20-4.
12. Taylor HR, Keeffe JE. World blindness: a 21st century perspective. Br J Ophthalmol 2001;85:261-6.
13. Jager RD, Mieler W F, Miller J W. Age-related macular degeneration. N Engl J Med 2008;358:2606-17.
14. Ho AC. Laser treatment in eyes with drusen. Curr Opin Ophthalmol 1999;10:204-8.
15. Soubrane G, Bressler NM. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy. Br J Ophthalmol 2001;85:483-95.
16. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44.
17. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31.
18. Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30, 000-molecular-weight protein. Proc Natl Acad Sci USA1969;64:787-94.
19. Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 1998;51:695-702.
20. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 1998;27:1-39.
21. Chiaretti A, Piastra M, Caresta E, Nanni L, Aloe L. Improving ischaemic skin revascularisation by nerve growth factor in a child with crush syndrome. Arch Dis Child 2002;87:446-8.
22. Di Fausto V, Fiore M, Tirassa P, Lambiase A, Aloe L. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur J Neurosci 2007;26:2473-80.
23. Williams BJ, Eriksdotter-Jonhagen M, Granholm AC. Nerve growth factor in treatment and pathogenesis of Alzheimer's disease. Prog Neurobiol 2006;80:114-28.
24. Lambiase A, Centofanti M, Micera A, Manni GL, Mattei E, De Gregorio A, de Feo G, Bucci MG, Aloe L. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol 1997;235:780-5.
25. Siliprandi R, Canella R, Carmignoto G. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci 1993;34:3232-45.
26. Lambiase A, Tirassa P, Micera A, Aloe L, Bonini S. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci 2005;46:3800-6.
27. Lambiase A, Pagani L, Di Fausto V, Sposato V, Coassin M, Bonini S, Aloe L. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res 2007;1127:45-51.
28. Shimohama S, Ogawa N, Tamura Y, Akaike A, Tsukahara T, Iwata H, Kimura J. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res 1993;632:296-302.
29. Verge VM, Merlio JP, Grondin J, Ernfors P, Persson H, Riopelle RJ, Hökfelt T, Richardson PM. Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci 1992;12:4011-22.
30. Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci 1989;9:1263-72.
31. Lambiase A, Aloe L, Centofanti M, Parisi V, Mantelli F, Colafrancesco V, Manni GL, Bucci MG, Bonini Dt, Levi-Montalcini T. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implication for galucoma. PNAS 2009;106:13469-74.